Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians.
about
Altered proteolysis in fibroblasts of Alzheimer patients with predictive implications for subjects at risk of diseaseMicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s DiseaseCanadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada.Platelet phosphorylated TDP-43: an exploratory study for a peripheral surrogate biomarker development for Alzheimer's disease.
P2860
Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Fluid biomarkers for diagnosin ...... tions for Canadian physicians.
@en
Fluid biomarkers for diagnosin ...... tions for Canadian physicians.
@nl
type
label
Fluid biomarkers for diagnosin ...... tions for Canadian physicians.
@en
Fluid biomarkers for diagnosin ...... tions for Canadian physicians.
@nl
prefLabel
Fluid biomarkers for diagnosin ...... tions for Canadian physicians.
@en
Fluid biomarkers for diagnosin ...... tions for Canadian physicians.
@nl
P2093
P2860
P356
P1476
Fluid biomarkers for diagnosin ...... tions for Canadian physicians.
@en
P2093
CCDTD4 participants
Ging-Yuek Hsiung
Mario Masellis
P2860
P2888
P356
10.1186/ALZRT223
P407
P433
P577
2013-11-25T00:00:00Z
P5875
P6179
1049956391